|
Atomistry » Fluorine » PDB 4c6l-4cqj » 4cmo | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4c6l-4cqj » 4cmo » |
Fluorine in PDB 4cmo: Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-MethylbenzamideEnzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide
All present enzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide:
2.7.10.1; Protein crystallography data
The structure of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide, PDB code: 4cmo
was solved by
M.A.Mctigue,
Y.L.Deng,
W.Liu,
A.Brooun,
A.E.Stewart,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide
(pdb code 4cmo). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide, PDB code: 4cmo: Fluorine binding site 1 out of 1 in 4cmoGo back to Fluorine Binding Sites List in 4cmo
Fluorine binding site 1 out
of 1 in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide
Mono view Stereo pair view
Reference:
T.W.Johnson,
P.F.Richardson,
S.Bailey,
A.Brooun,
B.J.Burke,
M.R.Collins,
J.J.Cui,
J.G.Deal,
Y.L.Deng,
D.M.Dinh,
L.D.Engstrom,
M.He,
J.E.Hoffman,
R.L.Hoffman,
Q.Huang,
J.Kath,
R.S.Kania,
H.Lam,
J.L.Lam,
P.T.Le,
L.Lingardo,
W.Liu,
M.A.Mctigue,
C.L.Palmer,
N.W.Sach,
T.Smeal,
G.L.Smith,
A.E.Stewart,
S.L.Timofeevski,
H.Zhu,
J.Zhu,
H.Y.Zou,
M.P.Edwards.
Discovery of (10R)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15- Oxo-10,15,16,17-Tetrahydro-2H-8,4-(Metheno)Pyrazolo[4,3- H][2,5,11]Benzoxadiazacyclotetradecine-3-Carbonitrile (Pf- 06463922), A Macrocyclic Inhibitor of Alk/ROS1 with Pre- Clinical Brain Exposure and Broad Spectrum Potency Against Alk-Resistant Mutations. J.Med.Chem. V. 57 4720 2014.
Page generated: Sun Dec 13 12:00:33 2020
ISSN: ISSN 0022-2623 PubMed: 24819116 DOI: 10.1021/JM500261Q |
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |